Equity Capital Markets

Company · CIK 1664710

Keros Therapeutics, Inc.

CIK1664710 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Business addressMA
ListedKROS (Nasdaq)
First annual or quarterly report2020-05-22

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-298854
ShelfEffective
 2026-09-102026-09-162
333-279094
ShelfEffective
 2024-05-032024-06-172
333-255724
ShelfEffective
 2021-05-032024-01-044
333-250010
Registered companyFinal prospectus
 2020-11-102020-11-133
333-237212
IPOFinal prospectus
 2020-03-162020-04-085

Filings

18
FiledFilingRegistrationAccession
2026-09-16EFFECTDeclared effective 333-2988549999999995-26-002985
2026-09-10S-3Shelf registered 333-2988540001628280-26-061321
2024-06-17424B5Shelf takedown 333-2790940001628280-24-028534
2024-05-03S-3ASRShelf registered 333-2790940001628280-24-020141
2024-01-04424B5Shelf takedown 333-2557240001628280-24-000429
2024-01-03424B5Shelf takedown 333-2557240001628280-24-000192
2022-12-12424B5Shelf takedown 333-2557240001628280-22-031721
2021-05-03S-3ASRShelf registered 333-2557240001628280-21-008617
2020-11-13424B4Final prospectus 333-2500100001628280-20-016415
2020-11-12EFFECTDeclared effective 333-2500109999999995-20-003170
2020-11-10S-1Registration filed 333-2500100001628280-20-016204
2020-11-03DRSDraft made public 377-037370001628279-20-000305
2020-04-08424B4Final prospectus 333-2372120001193125-20-101456
2020-04-07EFFECTDeclared effective 333-2372129999999995-20-000699
2020-04-07S-1/AAmendment 333-2372120001193125-20-099735
2020-04-01S-1/AAmendment 333-2372120001193125-20-093365
2020-03-16S-1Registration filed 333-2372120001193125-20-074978
2020-01-21DRSDraft made public 377-030010000950123-20-000379

All filings of this company · CSV